SCHEMBL20825331

SCHEMBL20825331

CCCCOCCOCCOCCOC(C)C

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.48
CYP3A4 P08684 2/20 0.46
MAPT P10636 2/20 0.43
MEN1 O00255 1/20 0.43
THRB P10828 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
ADRB3 P13945 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
HPGD P15428 1/20 0.35
EPHX2 P34913 1/20 0.35
HSD17B10 Q99714 1/20 0.34
SPHK1 Q9NYA1 1/20 0.33
USP2 O75604 1/20 0.33
RARB P10826 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7585280 1.00 TSHR (0.48) TSHRCYP3A4MAPTMEN1THRB
SCHEMBL3419111 1.00 TSHR (0.48) TSHRCYP3A4MAPTMEN1THRB
SCHEMBL4838940 1.00 TSHR (0.48) TSHRCYP3A4MAPTMEN1THRB
SCHEMBL4840053 0.93 HTT (0.52) TSHRCYP3A4MAPTMEN1THRB
SCHEMBL27888500 0.93 HTT (0.52) TSHRCYP3A4MAPTMEN1THRB
SCHEMBL24754956 0.91 HTT (0.56) TSHRCYP3A4MAPTMEN1THRB
SCHEMBL18510366 0.91 HTT (0.56) TSHRCYP3A4MAPTMEN1THRB
SCHEMBL18510372 0.91 HTT (0.56) TSHRCYP3A4MAPTMEN1THRB
SCHEMBL20206377 0.91 HTT (0.56) TSHRCYP3A4MAPTMEN1THRB
SCHEMBL25341871 0.91 HTT (0.56) TSHRCYP3A4MAPTMEN1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021178597-A1 ANTIBODIES COMPRISING SITE-SPECIFIC GLUTAMINE TAGS, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE SUTRO BIOPHARMA, INC. (US) 2021-09-10 WO disclosed
WO-2020257235-A1 1-(4-(AMINOMETHYL)BENZYL)-2-BUTYL-2H-PYRAZOLO[3,4-C]QUINOLIN-4-AMINE DERIVATIVES AND RELATED COMPOUNDS AS TOLL-LIKE RECEPTOR (TLR) 7/8 AGONISTS, AS WELL AS ANTIBODY DRUG CONJUGATES THEREOF FOR USE IN CANCER THERAPY AND DIAGNOSIS SUTRO BIOPHARMA, INC. (US) 2020-12-24 WO disclosed
WO-2019055931-A1 ANTI- FOLATE RECEPTOR ALPHA ANTIBODY CONJUGATES AND THEIR USES SUTRO BIOPHARMA, INC. (US) 2019-03-21 WO disclosed